Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic

Sexually Transmitted Diseases

Volumn 29, Issue 12, 2002, Pages 763-768

  Brown, Darron R ^a,b   Legge, Denise ^a   Qadadri, Brahim ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BLOTTING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; HIGH RISK POPULATION; HUMAN; LAVAGE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS DIAGNOSIS; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

EID: 0036896029     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200212000-00005     Document Type: Article

References (16)

1. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995; 76:1888-1901.
2. Schiffman MH, Burk RD. Human papillomaviruses. In: Evans AS, Kaslow RA. eds. Viral Infections of Humans. New York: Plenum Medical Book Company, 1997:983-1022.
3. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19.
4. Asato T, Nakajima Y, Nagamine M, et al. Correlation between the progression of cervical dysplasia and the prevalence of human papillomavirus. J Infect Dis 1994; 169:940-941.
5. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102:3-8.
6. Lamb M. Cervical cancer screening of women attending sexually transmitted disease clinics. Clin Infect Dis 1995; 20(Suppl 1):98-103.
7. Figueroa JP, Ward E, Luthi TE. et al. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: Association of younger age and increased sexual activity. Sex Transm Dis 1995; 22:114-118.
8. Svare EL, Kjaer SK, Worm AM, et al. Risk factors for HPV infection in women from sexually transmitted disease clinics: Comparison between two areas with different cervical cancer incidence. Int J Cancer 1998; 75:1-8.
9. Brown DR, McClowry TL, Woods K, Fife KH. Nucleotide sequence and characterization of human papillomavirus type 83, a novel genital papillomavirus. Virology 1999; 260:165-172.
10. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 HPV types from L1 consensus PCR products using a single hybridization, reverse line-blot detection method. J Clin Microbiol 1998; 36:3020-3027.
11. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357-361.
12. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999; 37:3316-3322.
13. Ho GYF, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87:1365-1371.
14. Swan DC, Tucker RA, Tortolero-Luna G, et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 1999; 37:1030-1034.
15. Rousseau M-C, Pereira J, Prado J, et al. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001; 184:1508-1517.
16. Fife K, Cramer H, Schroeder J, Brown D. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 2001; 64:550-559.